Nutra Pharma Corp (NPHC) Debt Ratio (2010 - 2026)

Nutra Pharma has disclosed Debt Ratio across 17 years of filings, most recently posting 3.49 for Q2 2026.

• In Q2 2026, Debt Ratio fell 71.22% year-over-year to 3.49; the TTM figure through Jun 2026 stood at 3.49 (down 71.22% YoY), while the FY2025 annual figure was 17.22, up 10.54% from the prior year.
• Debt Ratio came in at 3.49 for Q2 2026 at Nutra Pharma, up from 2.0 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 27.91 in Q1 2024 to a low of 2.0 in Q1 2026.
• Average Debt Ratio over 5 years is 17.84, with a median of 17.91 recorded in 2022.
• Year-over-year, Debt Ratio jumped 108.06% in 2023 and plunged 85.58% in 2026.
• Over 5 years, Debt Ratio stood at 13.1 in 2022, then jumped by 108.06% to 27.27 in 2023, then sank by 42.87% to 15.58 in 2024, then rose by 10.54% to 17.22 in 2025, then sank by 79.75% to 3.49 in 2026.
• Per Business Quant data, the three most recent Debt Ratio figures were 3.49 in Q2 2026, 2.0 in Q1 2026, and 17.22 in Q4 2025.